Respiratory Care Devices Market Analysis and Forecast to 2031: By Product (Positive Airway Pressure (PAP) Devices {Continuous Positive Airway Pressure [CPAP] Devices, Auto-titrating Positive Airway Pressure [APAP] Devices, Bi-level Positive Airway Pressur

Respiratory Care Devices Market Analysis and Forecast to 2031: By Product (Positive Airway Pressure (PAP) Devices {Continuous Positive Airway Pressure [CPAP] Devices, Auto-titrating Positive Airway Pressure [APAP] Devices, Bi-level Positive Airway Pressure [BiPAP] Devices}, Oxygen Concentrators {Fixed Oxygen Concentrators, Portable Oxygen Concentrators}, Ventilators {Adult Ventilators, Neonatal Ventilators}, Inhalers {Metered Dose Inhaler [MDI], Dry Powder Inhaler [DPI], Soft Mist Inhaler [SMI]}, Nebulizers {Compressor-based Nebulizers, Piston-based Hand-held Nebulizers, Ultrasonic Nebulizers}, Humidifiers {Heated Humidifiers, Passover Humidifiers, Integrated Humidifiers, Built-in Humidifiers, Standalone Humidifiers}), By Application (COPD, Obstructive Sleep Apnea, Asthma, Respiratory Distress Syndrome, Cystic Fibrosis), By End-use (Hospital, Homecare Settings, Emergency Centers),and Region

The global respiratory care devices market was valued at USD 47.3 billion in 2021 and it is anticipated to grow up to USD 72.8 billion by 2031, at a CAGR of 4.4% during the forecast period.


Respiratory care devices are used for diagnosis, monitoring, and treatment of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, tuberculosis, and pneumonia. These devices provide enhanced care to patients suffering from such acute and chronic respiratory diseases. The report analyzes the respiratory care devices market on the basis of product type, end user, and geography.

Global Respiratory Care Devices Market Scope and Report Structure

Market Trends and Drivers

Outbreak of infectious diseases affecting the respiratory system thus will increases the demand for respiratory care devices thereby augmenting the market growth. Infectious respiratory diseases directly drive demand for respiratory care. COVID-19 is the most recent and significant of these diseases; the pandemic has resulted in a surge in demand for personal protection equipment and ventilators, among others. The demand for ventilators has also grown due to the COVID-19 outbreak, resulting in governmental and industrial support for driving the pace of manufacturing. This is indicative of the emphasis on respiratory care in the background of an outbreak; the market is expected to show a healthy growth rate, as a result.

Market Restraints and Challenges

Unfavorable reimbursement scenario may restrain the market growth. Many patients rely on reimbursements to receive treatment. The diagnostic industry as a whole and respiratory care diagnostics, in particular, is presently facing the challenge of lack of reimbursements for various diagnostic tests. Reimbursement policies are dispersed in Europe and are available only for PAP devices and oral appliances in select countries (devices that are not covered by insurance have a low market share in the region). Also, the majority of countries in the Asian and ROW regions have negligible reimbursement coverage for respiratory care devices.

Global Respiratory Care Devices Market Segmental Overview

The report analyses the global respiratory care devices market based on product, application, end use, and region.

Global Respiratory Care Devices Market by Product

Based on product, it is segmented into positive airway pressure (PAP) devices, oxygen concentrator, ventilators, inhalers, nebulizers, humidifiers, and others. Among these, the positive airway pressure devices segment accounted for significant market share in 2021 driven by growing product approval and new product launches due to technological advancements in therapeutic respiratory devices. The PAP devices are further divided into continuous positive airway pressure (CPAP) devices, auto-titrating positive airway pressure (APAP) devices, and bi-level positive airway pressure (BiPAP) devices. PAP devices open patients’ airway and prevents it from collapsing while they are asleep, enabling them to breathe normally. For instance, in August 2021, ResMed launched AirSense11, a next-generation PAP therapy device. It has a feature of remote software update that ease into therapy and has comfort during night use. Such innovations in therapeutic respiratory devices will upsurge market growth during the analysis period.

Global Respiratory Care Devices Market by Application

Based on application, it is segmented into COPD, obstructive sleep apnea, asthma, respiratory distress syndrome, cystic fibrosis, and others. Among them, the chronic obstructive pulmonary disease (COPD) segment accounted for USD 12.6 billion in 2021 owing to the rising geriatric population along with increasing air pollution in urban areas. For instance, according to Sixth Annual COPD In America Survey, till 2020, it is estimated that more than 250 million people worldwide suffer from COPD because rise in exposure of smoke, and toxic particles. Furthermore, working with chemicals, dust and fumes further leads to inhalation of second-hand smoke. Moreover, new product launches to aid COPD cases will further propel the segmental growth. For instance, in November 2021, Cipla launched Spirofy, a portable, wireless spirometer. The device has bacterial and viral filters making it suitable for use in outdoor camps and remote regions with power shortages.

Global Respiratory Care Devices Market by End-use

Based on end-use, it is segmented into hospitals, homecare settings and emergency centers. The hospitals segment accounted for around USD 17 billion in 2021 owing to the increasing healthcare expenditure to provide a proper diagnosis, treatment, and improved patient care in hospitals. Furthermore, hospitals have trained professionals along with strong financials to purchase expensive medical devices. COVID-19 has also positively impacted the hospital segment. Also, according to data published by Public Health England in 2019, lung disease accounts for 700,000 hospital admissions every year. This rise in the number of diagnoses and treatments in hospitals will flourish the market growth. Such factors increase the demand for therapeutic respiratory devices in hospitals.

Geographical Analysis of Global Respiratory Care Devices Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America therapeutic respiratory devices market captured significant market share in 2021 and is expected to grow significantly during the forecast years owing to the presence of sophisticated healthcare facilities in the U.S. and Canada. Also, the increasing healthcare awareness along with improving healthcare infrastructure will augment the market growth. Moreover, the increasing incidences of respiratory infections across the U.S. coupled with rising healthcare spending is also expected to propel therapeutic respiratory devices market in the forthcoming years. For instance, according to the United States Death Statistics, in 2021, 44,630 people died due to respiratory diseases.

Major Players in the Global Respiratory Care Devices Market COVID-19 Impact

The impact of COVID-19 on the therapeutic respiratory devices industry is observed to be positive. This is because the virus mainly attacks the respiratory system of a person. The market forged ahead with the rise in the number of cases resulting in a positive impact. Therapeutic respiratory devices (TRDs) are used to improve pulmonary function, increase lung oxygenation, and aid in airway clearance by removing mucus from the bronchi. Doctors or physicians recommend therapeutic respiratory devices for the treatment of respiratory disorders because they help patients with both acute and chronic conditions. These devices require little maintenance and are simple to use. Therapeutic respiratory devices are quick to deploy and aid in proper patient care. The market demand for therapeutic respiratory devices is increasing as a result of ongoing technological advancements.

Recent Developments

• In December 2021, Medtronic's Covidien unit initiated a recall of Puritan Bennet 980 series ventilators due to a manufacturing error, marking the third Class I recall of the product since 2015. The recall was initiated due to a "manufacturing assembly error where a capacitor within the ventilator was assembled incorrectly.
• In August 2021, ResMed launched AirSense 11 PAP Series.
• In February 2021, Koninklijke Philips N.V. completed the acquisition of BioTelemetry, Inc., a U.S. based company. This helped in advancement of Philips product portfolio thus increasing its sales.
• In April 2021, Smiths Medical launched Acapella, a choice blue vibratory PAP therapy system. It is a drug-free supplemental treatment that aid in the removal of secretions for patients who have asthma, COPD, cystic fibrosis, and lung disease.
• In November 2020, Masimo announced that Radius VSM, a wearable, tetherless vital signs monitor, had received CE marking and was being released in limited European markets. The versatile, expandable Radius VSM provides the ability to monitor a wide variety of physiological measurements, including continuous SET pulse oximetry, noninvasive blood pressure, body temperature, respiration rate, and electrocardiography (ECG).

Frequently Asked Questions

Q1. How big is the respiratory care devices market market?Ans. The global respiratory care devices market size was USD 47.3 billion in 2021 and is anticipated to reach USD 72.8 billion in 2031, growing at a rate of 4.4% from 2022 to 2031.
Q2. What is the respiratory care devices market growth rate?Ans. The growth rate of the respiratory care devices market is 4.4%.
Q3. Which region holds a major market share for the sepsis diagnostics market?Ans. North America holds a major market share of the respiratory care devices market in 2021.
Q4. Which segment accounted for the largest respiratory care devices market share?Ans. By end user, the healthcare segment accounted for the largest respiratory care devices market share.
Q5. Who are the key players in the sepsis diagnostics market?Ans. The global respiratory care devices market report includes players such as
Q6. What are the factors driving the respiratory care devices market growth?Ans. The major factors driving the growth of the market are the rising incidence of HAI’s across the globe.
Q7. What are the key growth strategies of respiratory care devices market players?Ans. The key growth strategies of respiratory care devices market players are product launch and product approval.
Q8. Which region will provide more business opportunities for the respiratory care devices market during the forecast period?Ans. The Asia-Pacific region will provide more business opportunities for the respiratory care devices market during the forecast period.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.